Alexandra LEARY, MD,PHD
GINECO - Gustave Roussy
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alexandra LEARY, MD,PHD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:37 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04713514 · OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OCARCAGY/ GINECO GROUP · active not recruiting · Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer · principal investigator
- Ph1/Ph2NCT03249142 · Immunotherapy With Neo-adjuvant Chemotherapy for OVarian CancerARCAGY/ GINECO GROUP · completed · Ovarian Cancer
- Ph1NCT02978755 · First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological CancersGamaMabs Pharma · completed · Neoplasm, Gynecologic
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.